Cardiovascular diseases according to Plan
Cardiovascular diseases according to Plan
Ang presyon ng dugo ay isa sa mga pangunahing indikasyon ng kalusugan, na hindi lamang sumasalamin sa puso at sistema ng sirkulasyon, kundi pati na rin sa aktibidad ng mga bato, mga organo ng endokrin, paggawa ng dugo, at ng sistema ng nerbiyos. Kaya naman, walang isang unibersal na gamot laban sa mataas na presyon ng dugo. Hindi ka basta basta puwedeng pumunta sa botika at magtanong ng 'tableta para sa presyon,' kasi agad na tatanungin ng parmasyutiko – anong gamot ang nireseta sa iyo ng doktor?
>>> ПЕРЕЙТИ НА ОФИЦИАЛЬНЫЙ САЙТ <<<
Разделы:
- How to avoid cardiovascular disease
- Применение Cardiovascular diseases according to Plan
- Рекомендации
- Как купить?
- Отзывы покупателей
Описание
Minsan lang na biglaang pagtaas ng presyon o bahagyang mataas na resulta ay hindi palaging nangangailangan ng agarang pag-inom ng tableta. Lahat ng rekomendasyon ng mga espesyalista at ang mga magagamit na paraan ng pag-iwas ay mukhang simple lang, pero sa aktwal na buhay, ang maingat na pag-aalaga sa kalusugan ng dugo at sistema ng puso ay nakakaiwas sa biglaan at sobrang hindi kanais-nais na pagtaas ng presyon. Una sa lahat, ang mga Beta-blocker ay karaniwang ibinibigay sa mga pasyente na may heart failure, aortic aneurysm, pagkatapos ng myocardial infarction, at sa mga kababaihan na nasa edad ng pagbubuntis, lalo na sa mga kababaihang nagpaplano ng pagbubuntis. Madalas matanggap ng katawan ang Beta-blocker, pero maaari rin itong magdulot ng pantal sa balat at bradycardia – sobrang bagal ng tibok ng puso.
Как использовать Cardiovascular diseases according to Plan
If you have disturbed sleep, fatigue, disorientation, confusion, or nervousness, it's time to monitor your blood pressure. Either lack of sleep or too much sleeping might mean your blood pressure is high or low. If it’s left untreated, you will soon face an onslaught of multiple illnesses. How to avoid cardiovascular disease Prevention of the risks of cardiovascular diseases Diseases of the blood and of the cardiovascular SystemМнение специалиста
Sa pangunahing (esensyal) na altapresyon, ito ay dahil sa impluwensya ng namamana, hilig sa mataas na presyon ng dugo sa konteksto ng hindi malusog na pamumuhay, masamang gawi, hindi malusog na pagkain, na nagdudulot ng labis na timbang. Dagdag pa ang stress, kalikasan, kakulangan sa tulog at aktibidad. Lahat ito ay negatibong nakakaapekto sa trabaho ng puso at sa tono ng mga daluyan ng dugo. Ang presyon ay unang tumataas nang hindi napapansin at pagkatapos ay mas nagiging malinaw. Отзывы о Cardiovascular diseases according to Plan
Как заказать?
Заполните форму для консультации и заказа Cardiovascular diseases according to Plan. Оператор уточнит у вас все детали и мы отправим ваш заказ. Через 3-7 дней вы получите посылку и оплатите её при получении.
Отзывы покупателей
Диана: If you have disturbed sleep, fatigue, disorientation, confusion, or nervousness, it's time to monitor your blood pressure. Either lack of sleep or too much sleeping might mean your blood pressure is high or low. If it’s left untreated, you will soon face an onslaught of multiple illnesses.
Ева: The berries of Viburnum pressure in hypertension. Fact sheet on the topic of prevention of cardiovascular diseases. Dystonia diseases of the cardiovascular. Medicines for high blood pressure of the new Generation. Ang arteryal na hypertension o hypertension ay isang kondisyon ng patuloy na systolic at diastolic na presyon ng dugo, kung saan ang mga sukatan ay lumalagpas sa 140/90 mmHg. Ang mataas na presyon ay nagpapakita ng mga hindi komportableng sintomas.
Ева: Cardio Balance is formulated and made after years of rigorous research and clinical study of the ingredients. The unique combination of each ingredient brings out optimal effectiveness in supporting heart and blood pressure.
1 Cardiovascular Disorders — An effective remedy for high blood pressure
Prevention of the risks of cardiovascular diseases
New drugs against high blood pressure: progress and prospects High blood pressure, known medically as hypertension, is a worldwide health problem and is considered to be one of the main risk factors for cardiovascular diseases such as heart attack, stroke, and kidney damage. According to estimates by the world health organization (WHO) affects about one billion people worldwide have hypertension. The development of new drugs for the effective reduction of blood pressure is therefore of high clinical and social relevance. Current Therapy Approaches Traditional treatment strategies include various drug classes: ACE inhibitors (eg, Enalapril), which inhibit the formation of Angiotensin II; AT1‑receptor blockers (e.g., Losartan), which prevent the action of Angiotensin II to its receptors; Beta-blockers (e.g., Metoprolol), the lower the heart rate and force; Calcium channel blockers (e.g. amlodipine), which relax the smooth muscles of the blood vessels; Diuretics (such as hydrochlorothiazide) to reduce the liquid content in the body. In spite of this wide range of options that are resistant hypertension) remains a part of the patient's blood pressure is adequately controlled (or unwanted side effects. This motivates the search for new drugs. Latest Developments In the last few years, several innovative approaches have been developed: Endothelin‑receptor antagonists (e.g., Bosentan): they inhibit the effect of the strong Vasoconstrictor Endothelin‑1 and the show, especially in the case of special forms of hypertension (for example, in the case of chronic renal insufficiency), with promising results. Renin inhibitors (such as Aliskiren): By direct inhibition of the enzyme Renin, the whole of the Renin‑Angiotensin‑aldosterone System is broken‑cascade at an early stage. Studies show an effective reduction in blood pressure, however, must be evaluated in long-term data on safety more. Vasopeptidase inhibitors: Combined inhibition of Neprilysin (an enzyme that natriure degrades tables peptides) and ACE. This dual effect leads to greater vasodilation and Natriuresis. Immune therapeutic approaches: Experimental studies of antibodies against Angiotensin II or its receptors to investigate. This could allow a long-lasting blood pressure control. Gene and RNA‑based therapies: approaches to targeted inhibition of the Expression of blood pressure‑regulating proteins (e.g. by means of siRNA against AGTR1) are in preclinical phases. Clinical trials and effectiveness Several Phase III trials confirm the efficacy of new substances: In patients with resistant hypertension, the Addition of a Renin‑Inhibitor resulted in a significant reduction in systolic blood pressure by an average of 15.2 mmHg in comparison to the placebo group (p<0,001). Endothelin‑antagonists reduced the mean pulmonary arterial pressure in patients with pulmonary hypertension significantly (to be -10.3 mmHg, 95% CI: -13.1 with to -7.5). Challenges and future prospects Although these new drugs are promising, there are challenges: possible side effects (e.g., Hyperkalemia in Renin inhibitors); high costs in comparison to established therapies; Need for long-term data for the reduction of cardiovascular endpoints. The future of hypertension therapy is located in the personalization: Genetic testing that might allow prediction of individual efficacy and tolerability say. In addition, innovative delivery systems (for example, implants for continuous drug release) to open up new opportunities to improve therapy adherence. Conclusion The development of new drugs against high blood pressure expands the therapeutic options, and it provides patients with resistant or difficult-to-use yet hypertension, a new hope. Interdisciplinary research and innovative technologies will continue to drive progress in this area.
Diseases of the blood and of the cardiovascular System
Altai key in capsules made of high blood pressure
Die of cardiovascular diseases
Calculator to calculate the risk of cardiovascular diseases, https://72evakuator.ru/articles/20652-neck-massage-for-high-blood-pressure.html
Выводы Cardiovascular diseases according to Plan
Cardiovascular diseases: prevention, diagnosis and therapy according to a systematic Plan of action Introduction Cardiovascular diseases (HKK) is one of the leading causes of death worldwide and associated with significant socio-economic costs. Systematic planning in the prevention, diagnosis and treatment of these diseases can reduce the morbidity and mortality significantly. The present contribution outlines a structured approach to fighting cardiovascular diseases at all levels. 1. Prevention: risk factors to identify and minimize Effective prevention is based on the identification and modification of risk factors. Among the modifiable risk factors: Hypertension (blood pressure ≥140/90 mmHg), Dyslipidemia (elevated LDL‑cholesterol >3.0 mmol/l), Diabetes mellitus, Tobacco, Overweight and obesity (BMI ≥30 kg/m 2 ), Lack of movement, Dietary habits (high salt-, sugar -, and fat content). Primary preventive measures include health programmes, awareness campaigns and the promotion of a healthy lifestyle. 2. Early detection and diagnosis Dieuführliche history and clinical examination are the basis of any diagnostics. Other diagnostic procedures include: ECG (electrocardiogram) for the detection of arrhythmias and Ischemia, Echocardiography for the assessment of cardiac function and structure, Long‑term ECG and long‑term blood pressure measurement for the detection of arrhythmic events and fluctuations in blood pressure, Laboratory parameters: lipid spectrum, renal function, HbA1c, CRP, NT‑proBNP, Load tests (e.g., treadmill test) for the diagnosis of angina, Coronary angiography for suspected coronary heart disease (CHD). 3. Therapy: evidence-based and individualized treatment plans The therapy of HKK should always be evidence-based and on the individual patient's needs. They can be medical, interventional or surgical. Drug Therapy: Antihypertensive agents (ACE inhibitors, beta blockers, diuretics), Lipid-Lowering Drugs (Statins), Hypoglycemic agents in Diabetes, Anti Aggreganzien (Acetylsalicylic Acid, Clopidogrel), Anticoagulants in atrial fibrillation. Interventional Procedures: PTCA (percutaneous transluminal coronary angioplasty) with stent implantation, Cardioversion in the case of arrhythmias. Surgical Operations: Aortocoronary Bypass surgery (CABG), Valve replacement or repair, Implantation of defibrillators or pacemakers. 4. Rehabilitation and long-term care After acute events (e.g., myocardial infarction, stroke) is a structured Rehabilitation of Central importance. This includes: cardiac Rehabilitation (exercise therapy, endurance training), Nutrition advice psycho-social support, Training for self-management (blood pressure measurement, use of medication), regular follow-up examinations. Conclusion A systematic Plan for the control of cardiovascular diseases shall extend over all the phases: from primary prevention to early detection, targeted diagnostics, evidence-based therapy to long-term care. Through the implementation of such a Plan only individual health risks can be minimized, but also the overall societal burden of cardiovascular reduce diseases in a sustainable way.